Outcome of Board Meeting held for consideration and approval of the Consolidated and Standalone unaudited Financial Results for the half year ended 30th September, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.2 pts more than its Food Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shivam Chemicals' Board approved H1 FY26 (Apr–Sep 2025) results with strong year-on-year growth. Consolidated revenue from operations rose to ₹13,166.78 lakhs from ₹9,441.57 lakhs, a jump of about 39.5%. Profit before tax grew nearly 2.9x to ₹252.55 lakhs and profit after tax more than tripled to ₹196.51 lakhs (vs ₹58.02 lakhs), translating to EPS of ₹1.16 versus ₹0.34. On a standalone basis, revenue climbed about 45.6% to ₹12,486.95 lakhs and PAT rose to ₹154.60 lakhs from ₹87.82 lakhs. Statutory auditor PSRD & Co. issued an unmodified (clean) review opinion on both consolidated and standalone results.
Sharp revenue and profit growth alongside a clean auditor opinion is a positive signal for shareholders, indicating strong operational momentum. However, short-term borrowings nearly doubled (₹1,036 → ₹2,010 lakhs consolidated) and standalone operating cash flow turned negative, which investors should watch for working-capital stress despite the healthy bottom-line growth.